Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05887375 · ClinicalTrials.gov registry record · Phase 4
Sugammadex vs Neostigmine/Glycopyrrolate on Urinary Retention After Spine Surgery
A Phase 4 study, sponsored by University of Missouri-Columbia.
- Completed
- Registry status
- Phase 4
- Development phase
- 118
- Enrollment target
NCT05887375 is a Phase 4 study that has completed, run by University of Missouri-Columbia. The registered enrollment target is 118 participants.
The verdict
NCT05887375, a Phase 4 study, has completed, sponsored by University of Missouri-Columbia.
- COMPLETED
- Registry status
- Phase 4
- Development phase
- 118 participants
- Enrollment target
Study Summary
This is an active-comparator controlled study to evaluate the effect of sugammadex compared to neostigmine/glycopyrrolate for reversal of rocuronium on the incidence of urinary retention after subjects undergo elective ambulatory spine surgery.
Interventions
- DRUG Rocuronium
- DRUG Sugammadex
- DRUG Neostigmine
- DRUG Glycopyrrolate
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 118 participants |
| Start Date | 2023-08-03 |
| Est. Completion | 2026-01-15 |
| Phase | Phase 4 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT05887375
The ClinicalTrials.gov registry entry for NCT05887375 describes a study currently listed as completed, categorized as Phase 4. The registered enrollment target is 118 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of Missouri-Columbia, which has 291 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 4 interventions - of which Rocuronium is the first listed.
NCT05887375 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT05887375 about?
NCT05887375 is a clinical study titled "Sugammadex vs Neostigmine/Glycopyrrolate on Urinary Retention After Spine Surgery". This is an active-comparator controlled study to evaluate the effect of sugammadex compared to neostigmine/glycopyrrolate for reversal of rocuronium on the incidence of urinary retention after subjects undergo elective ambulatory spine surgery.
What is the current status of trial NCT05887375?
This trial is currently completed. It is a Phase 4 study. The enrollment target is 118 participants. The study started on 2023-08-03. Estimated completion is 2026-01-15.
What interventions are being tested in trial NCT05887375?
The interventions under investigation include: Rocuronium (DRUG), Sugammadex (DRUG), Neostigmine (DRUG), Glycopyrrolate (DRUG).
Who is sponsoring clinical trial NCT05887375?
This trial is sponsored by University of Missouri-Columbia, which has 291 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.